PL1809243T5 - Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy - Google Patents

Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy

Info

Publication number
PL1809243T5
PL1809243T5 PL05761637.7T PL05761637T PL1809243T5 PL 1809243 T5 PL1809243 T5 PL 1809243T5 PL 05761637 T PL05761637 T PL 05761637T PL 1809243 T5 PL1809243 T5 PL 1809243T5
Authority
PL
Poland
Prior art keywords
propellant
formulations containing
suspension formulations
aerosol suspension
aerosol
Prior art date
Application number
PL05761637.7T
Other languages
English (en)
Other versions
PL1809243T3 (pl
Inventor
Christel Schmelzer
Arne Froemder
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35169696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1809243(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004032322A external-priority patent/DE102004032322A1/de
Priority claimed from DE200510023334 external-priority patent/DE102005023334A1/de
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of PL1809243T3 publication Critical patent/PL1809243T3/pl
Publication of PL1809243T5 publication Critical patent/PL1809243T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PL05761637.7T 2004-07-02 2005-06-25 Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy PL1809243T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
DE200510023334 DE102005023334A1 (de) 2005-05-17 2005-05-17 Aeorosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
PCT/EP2005/006865 WO2006002840A2 (de) 2004-07-02 2005-06-25 Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
EP05761637.7A EP1809243B2 (de) 2004-07-02 2005-06-25 Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel

Publications (2)

Publication Number Publication Date
PL1809243T3 PL1809243T3 (pl) 2013-05-31
PL1809243T5 true PL1809243T5 (pl) 2022-12-27

Family

ID=35169696

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05761637.7T PL1809243T5 (pl) 2004-07-02 2005-06-25 Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy

Country Status (19)

Country Link
US (1) US8357352B2 (pl)
EP (1) EP1809243B2 (pl)
JP (1) JP5209963B2 (pl)
KR (1) KR101297061B1 (pl)
AR (1) AR049660A1 (pl)
AU (1) AU2005259523B2 (pl)
BR (1) BRPI0512878A (pl)
CA (1) CA2571519C (pl)
DK (1) DK1809243T4 (pl)
EA (1) EA013428B1 (pl)
EC (1) ECSP077126A (pl)
ES (1) ES2391563T5 (pl)
IL (1) IL180461A0 (pl)
MX (1) MXPA06015204A (pl)
NO (1) NO20070373L (pl)
NZ (1) NZ552869A (pl)
PL (1) PL1809243T5 (pl)
TW (1) TWI377943B (pl)
WO (1) WO2006002840A2 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006002840A2 (de) 2004-07-02 2006-01-12 Boehringer Ingelheim International Gmbh Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
GB2442745B (en) * 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
GB2442746B (en) 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US8389021B2 (en) * 2009-02-03 2013-03-05 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
WO2010112358A2 (de) 2009-03-31 2010-10-07 Boehringer Ingelheim International Gmbh Verfahren zur beschichtung einer oberfläche eines bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
MX2016014400A (es) 2014-05-07 2017-01-20 Boehringer Ingelheim Int Recipiente, nebulizador y uso.
UA121114C2 (uk) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Небулайзер, індикаторний пристрій і контейнер
US10322198B2 (en) 2016-07-08 2019-06-18 The Procter & Gamble Company Freshening compositions comprising isopropyl myristate

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
DE69324161T2 (de) * 1992-12-09 1999-10-28 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
EP0960830A1 (en) * 1993-04-30 1999-12-01 Minnesota Mining And Manufacturing Company Seal configuration for aerosol canister
AU680530B2 (en) * 1993-07-15 1997-07-31 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
TR199701170T1 (xx) * 1995-04-14 1998-02-21 Glaxo Wellcome Inc. Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) * 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
JP3801348B2 (ja) 1997-07-28 2006-07-26 株式会社ヴァレオサーマルシステムズ レシーバタンク
JP4117059B2 (ja) * 1998-02-10 2008-07-09 東洋エアゾール工業株式会社 高濃度粉末エアゾール製品
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
PT1102579E (pt) * 1998-08-04 2003-07-31 Jago Res Ag Formulacoes de aerossol medicinais
US5955958A (en) † 1998-10-05 1999-09-21 Lu; Kai Holiday candy jar with light and sound effects
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6739333B1 (en) * 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
WO2002005785A1 (en) † 2000-07-18 2002-01-24 Aeropharm Technology Incorporated Modulated release therapeutic aerosols
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
DE10043509A1 (de) 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
EP2258429A1 (en) 2001-06-26 2010-12-08 Norton Healthcare Limited An improved aerosol actuator
WO2003063843A1 (en) * 2002-02-01 2003-08-07 Astrazeneca Ab Composition for inhalation
BRPI0308274B8 (pt) * 2002-03-01 2021-05-25 Chiesi Farm Spa formulação de formoterol superfino
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) † 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
SI1565422T1 (sl) * 2002-11-22 2009-08-31 Lilly Co Eli Modulatorji vitamin d receptorja
EA009087B1 (ru) * 2003-03-20 2007-10-26 Бёрингер Ингельхайм Фармасьютиклз, Инк. Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов
AR041873A1 (es) † 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
WO2006002840A2 (de) 2004-07-02 2006-01-12 Boehringer Ingelheim International Gmbh Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
DE102004032322A1 (de) 2004-07-02 2006-02-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
JP2008524195A (ja) 2004-12-17 2008-07-10 シプラ・リミテッド 医薬化合物および組成物
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Also Published As

Publication number Publication date
ES2391563T3 (es) 2012-11-27
JP2008504325A (ja) 2008-02-14
DK1809243T4 (da) 2022-09-05
CA2571519C (en) 2013-05-14
TW200612945A (en) 2006-05-01
AU2005259523B2 (en) 2011-06-09
WO2006002840A8 (de) 2012-11-08
DK1809243T3 (da) 2012-10-15
PL1809243T3 (pl) 2013-05-31
TWI377943B (en) 2012-12-01
CA2571519A1 (en) 2006-01-12
MXPA06015204A (es) 2007-03-15
BRPI0512878A (pt) 2008-04-15
EP1809243B8 (de) 2013-02-27
AU2005259523A1 (en) 2006-01-12
KR20070042166A (ko) 2007-04-20
ES2391563T5 (es) 2022-10-26
NZ552869A (en) 2010-06-25
KR101297061B1 (ko) 2013-08-19
AR049660A1 (es) 2006-08-23
NO20070373L (no) 2007-01-31
EA200700042A1 (ru) 2007-08-31
EA013428B1 (ru) 2010-04-30
EP1809243B1 (de) 2012-07-18
US20060002863A1 (en) 2006-01-05
IL180461A0 (en) 2007-06-03
ECSP077126A (es) 2007-02-28
EP1809243B2 (de) 2022-06-08
WO2006002840A2 (de) 2006-01-12
WO2006002840A3 (de) 2006-11-16
JP5209963B2 (ja) 2013-06-12
EP1809243A2 (de) 2007-07-25
US8357352B2 (en) 2013-01-22

Similar Documents

Publication Publication Date Title
PL1809243T3 (pl) Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
AU2003301516A8 (en) Antifungal formulations
IL171941A0 (en) Pharmaceutical compositions containing a benzamide derivative
EP1385486A4 (en) NEW COATING OF SLOW RELEASE PHARMACEUTICAL COMPOSITION
AU2003276549A8 (en) Pharmaceutical compositions containing a biguanide-glitazone combination
GB2354006B (en) Electrostatic aerosol compositions
EP1539239A4 (en) NEW STABLE FORMULATION
ZA200609718B (en) Aerosol suspension formulations containing TG 227 EA or TG 134 A as a propellant
SG147453A1 (en) Pharmaceutical aerosol compositions
EP1480649A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS
AU151319S (en) Aerosol dispenser
GB2400484B (en) Weight Change Doll
GB0422816D0 (en) Preparation of suspension aerosol formulations
GB0207564D0 (en) Balance toy
GB0318753D0 (en) Aerosol can
CA94787S (en) Aerosol dispenser
CA94784S (en) Aerosol dispenser
GB0207335D0 (en) Cardboard toy
GB0426296D0 (en) Novel formulations
GB0426293D0 (en) Novel formulations
GB0420820D0 (en) Novel formulations
GB0427249D0 (en) Novel formulations
GB0427248D0 (en) Novel formulations
GB0427245D0 (en) Novel formulations
GB0420818D0 (en) Novel formulations